Nuwellis, Inc. has announced updated findings from the AVOID-HF study, indicating that the Aquadex® SmartFlow ultrafiltration therapy significantly reduces heart failure events by 60% compared to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback